Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 3/20 | 0.54 |
| ▸ | CA1 | P00915 | 3/20 | 0.54 |
| ▸ | CA2 | P00918 | 3/20 | 0.54 |
| ▸ | CNR2 | P34972 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 2/20 | 0.49 |
| ▸ | BCHE | P06276 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.46 |
| ▸ | VDR | P11473 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6906905 | 0.91 | CA1 (0.50) | CA9CA1CA2CNR2ALDH1A1 | |
| SCHEMBL18289524 | 0.91 | CA1 (0.50) | CA9CA1CA2CNR2ALDH1A1 | |
| SCHEMBL3884644 | 0.91 | CNR2 (0.46) | CA9CA1CA2CNR2ALDH1A1 | |
| SCHEMBL7028389 | 0.90 | CNR2 (0.50) | CA9CA1CA2CNR2ALDH1A1 | |
| SCHEMBL2310681 | 0.89 | FKBP1A (0.51) | CA9CA1CA2CNR2ALDH1A1 | |
| SCHEMBL18289526 | 0.89 | CYP19A1 (0.50) | CA9CA1CA2CNR2CA12 | |
| SCHEMBL31618044 | 0.88 | HTT (0.59) | CA9CA1CA2CA12CYP1A2 | |
| SCHEMBL10983891 | 0.88 | AR (0.58) | CA9CA1CA2CNR2CA12 | |
| SCHEMBL7459364 | 0.88 | FKBP1A (0.50) | CA9CNR2ALDH1A1CA12BCHE | |
| SCHEMBL6586284 | 0.88 | FKBP1A (0.50) | CA9CNR2ALDH1A1CA12BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 369 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113480455-B | Preparation method of mirabegron related substance and intermediate thereof | 浙江恒康药业股份有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-109526220-B | Tetrahydropyrimidine and tetrahydropyridino-diazepine compounds for use in the treatment of pain and pain related conditions | 埃斯特维制药股份公司 | 2021-12-21 | — | — | CN | claimed |
| US-6326122-B1 | HEAT SENSITIVE ELEMENTS | MITSUBISHI CHEMICAL CORPORATION (JP) | 2001-12-04 | — | — | US | claimed |
| EP-0375179-B1 | Copper plating process for difficult to plate metals | IBM (US) | 1994-05-25 | — | — | EP | claimed |
| US-4990224-A | Copper plating bath and process for difficult to plate metals | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1991-02-05 | — | — | US | claimed |
| JP-61165388-A | — | — | None | — | — | JP | disclosed |
| CN-122095297-A | Composition for forming cured film, alignment material, and phase difference material | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122029478-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | 日产化学株式会社 | 2026-05-12 | — | — | CN | disclosed |
| US-20260125417-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | LILLY CO ELI (US) | 2026-05-07 | — | — | US | disclosed |
| US-20250257265-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | NISSAN CHEMICAL CORPORATION (JP) | 2025-08-14 | — | — | US | disclosed |
| WO-2025127092-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-06-19 | — | — | WO | disclosed |
| CN-120051729-A | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | 日产化学株式会社 | 2025-05-27 | — | — | CN | disclosed |
| WO-1986004893-A1 | PROCESS FOR THE PREPARATION OF ALKYL FLUORIDES | ZAMBON S.P.A. (IT) | 1986-08-28 | — | — | WO | disclosed |
| JP-S61165388-A | PRODUCTION OF SPIROOXAZINE DERIVATIVE | TORAY IND INC | 1986-07-26 | — | — | JP | disclosed |
| EP-0171909-A1 | Spiro-oxazine compounds and preparation thereof and photochromic shaped article | TORAY INDUSTRIES, INC. (JP) | 1986-02-19 | — | — | EP | disclosed |
| EP-0003883-B1 | AMINO-DIBENZOPYRANS, THEIR PREPARATION, FORMULATIONS CONTAINING THEM AND THEIR USE AS PHARMACEUTICALS | ELI LILLY AND COMPANY (US) | 1982-10-06 | — | — | EP | disclosed |
| US-4195025-A | 9-Amino-dibenzopyrans | ELI LILLY AND COMPANY (US) | 1980-03-25 | — | — | US | disclosed |
| EP-0003883-A1 | Amino-dibenzopyrans, their preparation, formulations containing them and their use as pharmaceuticals | ELI LILLY AND COMPANY (US) | 1979-09-05 | — | — | EP | disclosed |
| US-4152450-A | 9-Amino-dibenzopyrans | ELI LILLY AND COMPANY (US) | 1979-05-01 | — | — | US | disclosed |
| US-3980678-A | Anthraquinone disperse dyes | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125417-A1 | GLUCOCORTICOID RECEPTOR AGONISTS | NR3C1, NR3C2, MC2R | CA9 3579/4885CA1 3110/4885CA2 1118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.